PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | C0024299|lymphoma |
| Sentences | 20 |
| PubMedID- 19705304 | Primary thyroid marginal zone b-cell lymphoma malt-type in a patient with rheumatoid arthritis. |
| PubMedID- 26236588 | Several studies have suggested an increased risk of lymphoma in patients with rheumatoid arthritis (ra). |
| PubMedID- 23705580 | Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment. |
| PubMedID- 19674036 | Association of marginal zone lymphoma with rheumatoid arthritis and resolution of lesions together with the resolution of symptoms due to rheumatoid arthritis after rituximab therapy is another interesting point for this case. |
| PubMedID- 20098085 | Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate. |
| PubMedID- 26509060 | Late-onset neutropenia rituximab was mainly reported in patients treated for lymphoma but data in patients with rheumatoid arthritis and other aids are very limited. |
| PubMedID- 26271620 | 5relative risk of non-hodgkin lymphoma in patients with rheumatoid arthritis (ra) compared with the general population. |
| PubMedID- 23793110 | Significant igg4+ plasma cell infiltrates were observed in rheumatoid arthritis, granulomatosis with polyangiitis, and lymphoma, underscoring the importance of histopathology in making the diagnosis of igg4-rd. |
| PubMedID- 19851770 | Anaplastic large cell lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 21369647 | The sir for lymphoma for patients with rheumatoid arthritis was 3.45 (1.83-5.89); all other indications reported sirs similar to those observed in the general population. |
| PubMedID- 25748956 | Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 25810835 | Oral non-hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate. |
| PubMedID- 23709423 | Use of immunosuppressive agents is also associated with lymphoproliferative disorders, as shown in methotrexate-related lymphoma in patients with rheumatoid arthritis.38 furthermore, reactivation or de novo infection of various pathogens, such as epstein-barr virus and human t-lymphotropic virus-1, are involved in not only hematological malignancies but also in several autoimmune and rheumatic diseases,39,40 which may be a consequence of therapeutic immunosuppression.41 the relationships between solid cancers, excluding the aforementioned cancers, and bd seem to be incidental. |
| PubMedID- 22825547 | Epstein-barr virus and methotrexate-related cns lymphoma in a patient with rheumatoid arthritis. |
| PubMedID- 21829083 | B-cell lymphoma possessing t(14;18)(q32;q21)in a patient with rheumatoid arthritis receiving methotrexate treatment. |
| PubMedID- 24811465 | Nasal type extranodal nk/t cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate. |
| PubMedID- 25610674 | Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate. |
| PubMedID- 26248810 | An unusual presentation of lymphoma in a patient with rheumatoid arthritis in remission. |
| PubMedID- 21729669 | The relationship between anti-tnf therapy and development of lymphoma in rheumatoid arthritis (ra) patients is controversial. |
| PubMedID- 25452189 | Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents. |
Page: 1